Modification of 3-arylisoquinolines into 3,4-diarylisoquinolines and assessment of their cytotoxicity and topoisomerase inhibition
作者:Daulat Bikram Khadka、Hyunjung Woo、Su Hui Yang、Chao Zhao、Yifeng Jin、Thanh Nguyen Le、Youngjoo Kwon、Won-Jea Cho
DOI:10.1016/j.ejmech.2015.01.016
日期:2015.3
Isoquinolinamine derivatives had greater affinity for topo I than for topo II. Topo inhibition by 3,4-diarylisoquinolines was further supported by docking models showing intercalative and/or H-bond interactions between these compounds and the DNA/topo(s). An analysis of the correlation between the cytotoxicity and topo inhibition of these compounds indicated that the primary biological target of derivatives with
受到单芳基异喹啉的初步成功的启发,并寻求寻找具有拓扑异构酶(拓扑)抑制活性的更有效和选择性的抗癌药,设计并合成了一系列二芳基异喹啉(3,4-二芳基异喹啉酮和3,4-二芳基异喹啉胺)。这些化合物的合成主要涉及锂化甲苯酰胺-苄腈的环加成,Suzuki偶联和亲核芳族取代反应。其中八种衍生物对人乳腺导管上皮肿瘤细胞(T47D),人前列腺癌细胞(DU145)和人结肠直肠腺癌细胞(HCT-15)有选择性毒性,但对正常人乳腺上皮细胞(MCF10A)没有影响。二芳基异喹啉化合物的拓扑抑制活性相对取决于它们的化学结构。3,4-二芳基异喹诺酮类通常不抑制topo I,而仅表现出对topo II的中等抑制作用。相反,几种3,4-二芳基异喹啉胺显示出优异的topo I抑制活性。异喹啉胺衍生物对topo I的亲和力大于对topo II的亲和力。对接模型进一步支持了3,4-二芳基异喹啉对拓扑的抑制作用,该模型显示了这些化合物与DNA